Cargando…
Risk Factors for Erythrocytosis in Renal Transplantation: Is Ganciclovir Therapy One of Them?
BACKGROUND: The purpose of this study was to identify the prevalence and risk factors of post-transplant erythrocytosis (PTE) and its relationship with cytomegalovirus (CMV). MATERIAL/METHODS: The study consisted of patients who received a kidney allograft and followed-up in our nephrology transplan...
Autores principales: | Koçak, Fatma Özge Kayhan, Bali, Musa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397145/ https://www.ncbi.nlm.nih.gov/pubmed/35982586 http://dx.doi.org/10.12659/AOT.936814 |
Ejemplares similares
-
Ganciclovir-resistant cytomegalovirus infection in renal transplantation
por: Vaz, Raquel, et al.
Publicado: (2014) -
Fatal lactic acidosis possibly related to ganciclovir therapy in a renal transplant patient?
por: Wittebole, Xavier, et al.
Publicado: (2015) -
Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation
por: Alasfar, Sami, et al.
Publicado: (2021) -
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome
por: Casale, Maddalena, et al.
Publicado: (2020) -
Predictability of Metabolic Syndrome Diagnosed by Body Mass Index for Cardiovascular Risk in Older Patients Treated with Levothyroxine
por: Koçak, Fatma Özge Kayhan, et al.
Publicado: (2022)